ReNeuron Group PLC banner
R

ReNeuron Group PLC
LSE:RENE

Watchlist Manager
ReNeuron Group PLC
LSE:RENE
Watchlist
Price: 3.375 GBX -2.17%
Market Cap: £1.9m

Balance Sheet

Balance Sheet Decomposition
ReNeuron Group PLC

Balance Sheet
ReNeuron Group PLC

Rotate your device to view
Balance Sheet
Currency: GBP
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
15
12
17
28
28
20
13
15
10
6
Cash
15
12
17
28
28
20
13
15
10
6
Short-Term Investments
6
0
43
25
10
6
0
8
5
1
Total Receivables
1
1
4
5
4
4
6
2
2
1
Accounts Receivables
0
0
0
0
1
1
0
0
0
0
Other Receivables
0
0
0
0
3
3
0
0
0
0
Other Current Assets
0
0
1
0
0
0
0
0
0
0
Total Current Assets
22
14
65
58
42
30
19
24
16
9
PP&E Net
0
0
0
1
1
1
1
1
1
1
PP&E Gross
0
0
0
1
0
0
1
1
1
1
Accumulated Depreciation
3
2
0
0
0
0
1
1
2
2
Intangible Assets
1
2
2
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
5
0
0
0
0
0
0
0
Total Assets
24
N/A
16
-33%
72
+347%
59
-18%
43
-26%
32
-27%
20
-35%
25
+24%
17
-32%
10
-44%
Liabilities
Accounts Payable
1
1
2
2
6
7
2
2
1
0
Accrued Liabilities
1
1
2
4
0
0
4
4
6
4
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
1
0
0
0
0
0
0
0
Total Current Liabilities
2
2
4
6
6
7
6
6
7
4
Long-Term Debt
0
0
0
0
1
1
1
1
0
0
Other Liabilities
0
1
0
0
0
0
0
0
0
0
Total Liabilities
2
N/A
3
+23%
4
+42%
6
+36%
7
+20%
8
+21%
7
-14%
6
-10%
7
+15%
5
-38%
Equity
Common Stock
18
18
32
32
0
0
0
1
1
1
Retained Earnings
42
51
62
76
61
75
85
96
105
109
Additional Paid In Capital
46
46
98
98
98
98
98
114
114
114
Total Equity
22
N/A
13
-40%
68
+415%
53
-21%
37
-31%
23
-36%
13
-43%
19
+43%
10
-48%
5
-49%
Total Liabilities & Equity
24
N/A
16
-33%
72
+347%
59
-18%
43
-26%
32
-27%
20
-35%
25
+24%
17
-32%
10
-44%
Shares Outstanding
Common Shares Outstanding
18
18
33
33
33
33
33
57
57
57
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett